Dracula, Measles, Mumps and Rubella: Economic lessons for why some are difficult to kill off
2019-07-08

Measles is a serious decease. So recent flare-ups have caused grave concerns. Many blame recurring outbreaks on misinformation leading some parents to the seemingly ill-judged decision not to vaccinate their children. Whilst there is undoubtedly truth in this narrative- there are other malevolent forces in play. For it is not clear why most infectious diseases refuse to go away. Like Dracula in Hammer Horror films they seem near impossible to kill off. Though every time at the end of a film Dracula has a wooden stake plunged through his heart, and the audience lets out a sigh of relief, collective amnesia still sets in when in the sequel the count reappears, fangs and all, ready to distribute the evils of the undead. And so it is with infectious diseases. As soon as an outbreak is over and we all relax we should not forget, unless the disease is irrevocably eradicated, that it will return to spread its harmful virus.

Despite medical progress, just one infectious disease has been defeated by human endeavour. It took nearly two hundred years from the small pox vaccination discovery of Edward Jenner in 1798 until small pox was declared eradicated by the World Health Organisation in 1980. So here are two puzzles. Why did it take so long to eliminate a disease when a vaccination had been available? And why have we failed to eradicate other infectious diseases?

Whilst the answers to these puzzles are many and complex involving logistic problems concerning the delivery of fully comprehensive and global reaching vaccination programs- there are also economic forces in play. Though economists are not best equipped to understand the chemistry of vaccinations, the medical efficacy or the logistic details of vaccination delivery- they possess instead a methodology capable of tracing the behavioural responses that make infectious diseases so very difficult to kill off.

There is not a vaccination around without side effects- some worse than others, some misunderstood and some grossly exaggerated through bad science. No matter, when looking through an economic lens- and we view the public health target individual as an economic agent, who naturally weighs the benefits of vaccinations against the perceived costs - we can draw some stark conclusions summarised in three economic lessons below.

Economic Lesson 1: The Problem. Typically, the problem of leaving vaccinations to individuals is one where personal choice does not necessarily coincide with what is socially optimal. That is, purely self-serving individuals do not necessarily consider the consequences to others. It is an example of what in economics is termed the problem of externalities. Whilst not choosing to vaccinate oneself may be perfectly rational, when the risks of the side effects seem too high- such individual decisions often ignore the detrimental effects on the wider population.

Economic Lesson 2: The Consequence. For the individual the benefit of a vaccination is the near certain avoidance of the disease. This benefit is greatest at the height of an outbreak, as illustrated under recent measles flare-ups in the UK, when the unprotected suddenly all flocked in panic to their GPs demanding vaccinations. However, as vaccination take-up rates increase, the prevalence rate declines and the benefit to the individual falls. At the same time the perceived personal risk from side-effects stays constant throughout. There comes a point for some when disease prevalence rates are low enough for the perceived risk of side effects to outweigh the benefits of vaccination. What then is the economic conclusion? Well, in short, it is that voluntary vaccinations alone are unlikely to eradicate a disease.

Economic Lesson 3: The Solution. Given the lessons above, is the Westminster Health Minister;Matt Hancock’s suggestion of making the MMR vaccination compulsory sensible? Whilst such a blunt tool could be proposed by some economists, economists more generally advocate so called Pigouvian taxes (subsidies) to rectify private under-provision. Thus, they seek to incentivise target groups by introducing a price of inaction (or reward for action). The individual refusing the vaccination is now compelled to pay a tax to reflect the magnitude of damage he/she is inflicting on society. The policy works as individuals seek to limit their tax liability. And with proper monitoring the only way to circumvent taxes is to vaccinate. If, as often argued, the damage to society is considerable then taxes must be substantial. A successful policy demands a high tax to ensure a sufficiently high compliance to eradicate the disease. Alternatively, governments/public health authorities could offer a subsidy to individuals who take the vaccination. Thus in this latter case “good behaviour” is rewarded and incentivised.

The Summary: Learning from the Lessons. These simple lessons tell us that individuals do not necessarily act in the interest of society. If unchecked this means diseases are very difficult to eradicate. However, all is not dark. There are tools available that are currently not utilised. A typical economic solution proposes using the tax system to incentivise individuals. For these vicious diseases finally to be laid to rest with wooden stakes plunged through their hearts, leaving absolutely no possibility of a sequel-requires the use of as many available instruments as possible. This short piece therefore argues for the inclusion of taxes and subsidies in the toolbox that together can be used to constitute and shape such wooden stakes.

Professor John Skåtun is an economist who specialises in theoretical models of the labour market, with a wider interest in health economics and the economics of epidemiology. Whilst primarily a micro-theorist, his work has a strong policy focus and also includes empirical articles on issues within labour economics.

A variation of this piece is published as a blog under the title ‘Economics, taxes and vaccines’ at:

https://www.eiuperspectives.economist.com/

https://eiuperspectives.economist.com/healthcare/economics-taxes-and-vaccines   

 
Published by Business School, University of Aberdeen

Comments

There are currently no comments for this post.

Your Comment

Search Blog

Browse by Month

2022

  1. Jan
  2. Feb There are no items to show for February 2022
  3. Mar
  4. Apr
  5. May There are no items to show for May 2022
  6. Jun There are no items to show for June 2022
  7. Jul There are no items to show for July 2022
  8. Aug There are no items to show for August 2022
  9. Sep There are no items to show for September 2022
  10. Oct There are no items to show for October 2022
  11. Nov There are no items to show for November 2022
  12. Dec There are no items to show for December 2022

2021

  1. Jan
  2. Feb
  3. Mar
  4. Apr
  5. May
  6. Jun There are no items to show for June 2021
  7. Jul There are no items to show for July 2021
  8. Aug There are no items to show for August 2021
  9. Sep
  10. Oct There are no items to show for October 2021
  11. Nov
  12. Dec

2020

  1. Jan
  2. Feb
  3. Mar
  4. Apr
  5. May There are no items to show for May 2020
  6. Jun There are no items to show for June 2020
  7. Jul
  8. Aug There are no items to show for August 2020
  9. Sep
  10. Oct
  11. Nov
  12. Dec There are no items to show for December 2020

2019

  1. Jan There are no items to show for January 2019
  2. Feb
  3. Mar
  4. Apr
  5. May
  6. Jun
  7. Jul
  8. Aug There are no items to show for August 2019
  9. Sep
  10. Oct
  11. Nov There are no items to show for November 2019
  12. Dec There are no items to show for December 2019

2018

  1. Jan
  2. Feb
  3. Mar
  4. Apr
  5. May There are no items to show for May 2018
  6. Jun
  7. Jul
  8. Aug
  9. Sep
  10. Oct
  11. Nov
  12. Dec There are no items to show for December 2018

2017

  1. Jan There are no items to show for January 2017
  2. Feb There are no items to show for February 2017
  3. Mar There are no items to show for March 2017
  4. Apr There are no items to show for April 2017
  5. May There are no items to show for May 2017
  6. Jun There are no items to show for June 2017
  7. Jul There are no items to show for July 2017
  8. Aug There are no items to show for August 2017
  9. Sep There are no items to show for September 2017
  10. Oct There are no items to show for October 2017
  11. Nov
  12. Dec